Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2010 1
2013 1
2014 1
2015 1
2019 1
2020 2
2021 3
2022 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for martin capa
Your search for Martin Cápay retrieved no results
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
Verweij PE, Rijnders BJA, Brüggemann RJM, Azoulay E, Bassetti M, Blot S, Calandra T, Clancy CJ, Cornely OA, Chiller T, Depuydt P, Giacobbe DR, Janssen NAF, Kullberg BJ, Lagrou K, Lass-Flörl C, Lewis RE, Liu PW, Lortholary O, Maertens J, Martin-Loeches I, Nguyen MH, Patterson TF, Rogers TR, Schouten JA, Spriet I, Vanderbeke L, Wauters J, van de Veerdonk FL. Verweij PE, et al. Intensive Care Med. 2020 Aug;46(8):1524-1535. doi: 10.1007/s00134-020-06091-6. Epub 2020 Jun 22. Intensive Care Med. 2020. PMID: 32572532 Free PMC article.
The IAPA case definitions may be useful to classify patients with COVID-19-associated pulmonary aspergillosis (CAPA), while awaiting further studies that provide more insight into the interaction between Aspergillus and the SARS-CoV-2-infected lung. CONCLUSION: A consensus …
The IAPA case definitions may be useful to classify patients with COVID-19-associated pulmonary aspergillosis (CAPA), while awaiting …
Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
Machado M, Valerio M, Álvarez-Uría A, Olmedo M, Veintimilla C, Padilla B, De la Villa S, Guinea J, Escribano P, Ruiz-Serrano MJ, Reigadas E, Alonso R, Guerrero JE, Hortal J, Bouza E, Muñoz P; COVID-19 Study Group. Machado M, et al. Mycoses. 2021 Feb;64(2):132-143. doi: 10.1111/myc.13213. Epub 2020 Nov 29. Mycoses. 2021. PMID: 33210776 Free PMC article. Review.
OBJECTIVES: Information on the recently COVID-19-associated pulmonary aspergillosis (CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU patients with coronavirus disease 2019 (COVID-19), and review the published literature from We …
OBJECTIVES: Information on the recently COVID-19-associated pulmonary aspergillosis (CAPA) entity is scarce. We describe eight CAP …
Disruption of information processing in schizophrenia: The time perspective.
Giersch A, Poncelet PE, Capa RL, Martin B, Duval CZ, Curzietti M, Hoonacker M, van Assche M, Lalanne L. Giersch A, et al. Schizophr Res Cogn. 2015 May 8;2(2):78-83. doi: 10.1016/j.scog.2015.04.002. eCollection 2015 Jun. Schizophr Res Cogn. 2015. PMID: 29114456 Free PMC article. Review.
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
Verweij PE, Brüggemann RJM, Azoulay E, Bassetti M, Blot S, Buil JB, Calandra T, Chiller T, Clancy CJ, Cornely OA, Depuydt P, Koehler P, Lagrou K, de Lange D, Lass-Flörl C, Lewis RE, Lortholary O, Liu PL, Maertens J, Nguyen MH, Patterson TF, Rijnders BJA, Rodriguez A, Rogers TR, Schouten JA, Wauters J, van de Veerdonk FL, Martin-Loeches I. Verweij PE, et al. Intensive Care Med. 2021 Aug;47(8):819-834. doi: 10.1007/s00134-021-06449-4. Epub 2021 Jun 23. Intensive Care Med. 2021. PMID: 34160631 Free PMC article.
Most patients diagnosed with CAPA lack traditional host factors, but pre-existing structural lung disease and immunomodulating therapy may predispose to CAPA risk. ...As the mortality of CAPA is around 50%, antifungal therapy is recommended for BAL positive p …
Most patients diagnosed with CAPA lack traditional host factors, but pre-existing structural lung disease and immunomodulating therap …
Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
Giusiano G, Fernández NB, Vitale RG, Alvarez C, Ochiuzzi ME, Santiso G, Cabeza MS, Tracogna F, Farías L, Afeltra J, Noblega LM, Giuliano CV, Garcia-Effron G. Giusiano G, et al. Med Mycol. 2022 May 18;60(5):myac026. doi: 10.1093/mmy/myac026. Med Mycol. 2022. PMID: 35394043 Free PMC article.
A multicenter prospective study was performed to evaluate the CAPA incidence in Argentina and to assess the performance of the lateral flow assay with digital readout (Sona Aspergillus LFA) as a CAPA diagnostic and screening tool. ...The overall mortality was 36.21% …
A multicenter prospective study was performed to evaluate the CAPA incidence in Argentina and to assess the performance of the latera …
The novel Mechanical Ventilator Milano for the COVID-19 pandemic.
Abba A, Accorsi C, Agnes P, Alessi E, Amaudruz P, Annovi A, Desages FA, Back S, Badia C, Bagger J, Basile V, Batignani G, Bayo A, Bell B, Beschi M, Biagini D, Bianchi G, Bicelli S, Bishop D, Boccali T, Bombarda A, Bonfanti S, Bonivento WM, Bouchard M, Breviario M, Brice S, Brown R, Calvo-Mozota JM, Camozzi L, Camozzi M, Capra A, Caravati M, Carlini M, Ceccanti A, Celano B, Cela Ruiz JM, Charette C, Cogliati G, Constable M, Crippa C, Croci G, Cudmore S, Dahl CE, Dal Molin A, Daley M, Di Guardo C, D'Avenio G, Davignon O, Del Tutto M, De Ruiter J, Devoto A, Diaz Gomez Maqueo P, Di Francesco F, Dossi M, Druszkiewicz E, Duma C, Elliott E, Farina D, Fernandes C, Ferroni F, Finocchiaro G, Fiorillo G, Ford R, Foti G, Fournier RD, Franco D, Fricbergs C, Gabriele F, Galbiati C, Garcia Abia P, Gargantini A, Giacomelli L, Giacomini F, Giacomini F, Giarratana LS, Gillespie S, Giorgi D, Girma T, Gobui R, Goeldi D, Golf F, Gorel P, Gorini G, Gramellini E, Grosso G, Guescini F, Guetre E, Hackman G, Hadden T, Hawkins W, Hayashi K, Heavey A, Hersak G, Hessey N, Hockin G, Hudson K, Ianni A, Ienzi C, Ippolito V, James CC, Jillings C, Kendziora C, Khan S, Kim E, King M, King S, Kittmer A, Kochanek I, … See abstract for full author list ➔ Abba A, et al. Phys Fluids (1994). 2021 Mar;33(3):037122. doi: 10.1063/5.0044445. Epub 2021 Mar 23. Phys Fluids (1994). 2021. PMID: 33897243 Free PMC article.
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
Ghazanfari M, Yazdani Charati J, Davoodi L, Arastehfar A, Moazeni M, Abastabar M, Haghani I, Mayahi S, Hoenigl M, Pan W, Hedayati MT. Ghazanfari M, et al. Mycoses. 2022 Oct;65(10):960-968. doi: 10.1111/myc.13518. Epub 2022 Aug 25. Mycoses. 2022. PMID: 35979737 Free PMC article.
BACKGROUND: Galactomannan Enzyme Immunoassay (GM-EIA) is proved to be a cornerstone in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA), its use is limited in middle and low-income countries, where the application of simple and rapid test, including Gala …
BACKGROUND: Galactomannan Enzyme Immunoassay (GM-EIA) is proved to be a cornerstone in the diagnosis of COVID-19-associated pulmonary asperg …
Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID).
Desmedt L, Raymond M, Le Thuaut A, Asfar P, Darreau C, Reizine F, Colin G, Auchabie J, Lorber J, La Combe B, Kergoat P, Hourmant B, Delbove A, Frérou A, Morin J, Ergreteau PY, Seguin P, Martin M, Reignier J, Lascarrou JB, Canet E. Desmedt L, et al. Ann Intensive Care. 2024 Jan 29;14(1):17. doi: 10.1186/s13613-023-01229-3. Ann Intensive Care. 2024. PMID: 38285382 Free PMC article.
The primary objective was to determine the incidence of proven/probable CAPA, and the secondary objectives were to identify risk factors for proven/probable CAPA and to assess associations between proven/probable CAPA and patient outcomes. ...Corticosteroids …
The primary objective was to determine the incidence of proven/probable CAPA, and the secondary objectives were to identify risk fact …
Re-description of Parasphaerosyllisindica Monro, 1937 (Annelida, Syllidae), with the establishment of a new species from western Mexico.
Góngora-Garza G, Tovar-Hernández MA, de León-González JA. Góngora-Garza G, et al. Biodivers Data J. 2024 Jan 31;12:e116082. doi: 10.3897/BDJ.12.e116082. eCollection 2024. Biodivers Data J. 2024. PMID: 38333070 Free PMC article.
BACKGROUND: Parasphaerosyllis Monro, 1937 is a syllid genus, currently composed of four species: P.indica Monro, 1937 from the Arabian Sea, P.uschakovi (Chlebovitsch, 1959) from the Kurile Islands, P.ezoensis Imajima & Hartman, 1964 from Japan and P.malimalii Capa, San …
BACKGROUND: Parasphaerosyllis Monro, 1937 is a syllid genus, currently composed of four species: P.indica Monro, 1937 from the Arabian Sea, …
14 results